IGF-I increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 4 39-4, 1996, Pages

  Reape, Theresa J ^a,b   Kanczler, Janos M ^a   Ward, Jeremy P T ^a   Thomas, Chris R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

deoxyribonucleic acid synthesis; proliferation; rabbit aortic smooth muscle cells; receptor modulation; synergy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; RECEPTOR PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; AORTA MEDIA; ARTERY INJURY; ARTERY WALL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG POTENTIATION; MALE; MITOGENESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0029965490     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.4.h1141     Document Type: Article

References (36)

1. Bagby, S. P., E. A. Kirk, L. H. Mitchell, M. M. O'Reilly, W. E. Holden, P. E. Stenberg, and A. C. Bakke. Proliferative synergy of ANG II and EGF in porcine aortic vascular smooth muscle cells. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F239-F249, 1993.
2. Bobik, A., and J. H. Campbell. Vascular-derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol. Rev. 45: 2-42, 1993.
3. Brogi, E., J. A. Winkles, R. Underwood, S. K. Clinton, G. E. Alberts, and P. Libby. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J. Clin. Invest. 92: 2408-2418, 1993.
4. Casscells, W., D. A. Lappi, B. B. Olwin, C. Wai, M. Siegman, E. Speir, J. Sasse, and A. Baird. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc. Natl. Acad. Sci. USA 89: 7159-7163, 1992.
5. Chirgwin, J. M., A. E. Pryzbyla, R. J. MacDonald, and W. J. Rutter. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
6. Chomoczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
7. Cohick, W. S., and D. R. Clemmons. The insulin-like growth factors. Annu. Rev. Physiol. 55: 131-153, 1993.
8. Ferns, G. A. A., E. W. Raines, K. H. Sprugel, A. S. Motani, M. A. Reidy, and R. Ross. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science Wash. DC 253: 1129-1132, 1991.
9. Givol, D., and A. Yayon. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6: 3362-3369, 1992.
10. Goto, F., K. Goto, K. Weindel, and J. Folkman. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69: 508-517, 1993.
11. Grant, M. B., T. J. Wargovich, E. S. Ellis, S. Caballero, M. Mansour, and C. J. Pepine. Localization of insulin-like growth factor-I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation 89: 1511-1517, 1994.
12. Hughes, S. E., D. Crossman, and P. A. Hall. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc. Res. 27: 1214-1219, 1993.
13. Jackson, A., S. Friedman, X. Zhan, K. A. Engleka, R. Forough, and T. Maciag. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 89: 10691-10695, 1992.
14. 1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J. Cell. Physiol. 150: 232-242, 1992.
15. Khorsandi, M. J., J. A. Fagin, D. Giannella-Neto, J. S. Forrester, and B. Cerek. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J. Clin. Invest. 90: 1926-1931, 1992
16. Kirschenlohr, H., J. Metcalfe, P. L. Weissberg, and D. J Grainger. Adult human aortic smooth muscle cells in culture produce active TGF-β. Am. J. Physiol. 265 (Cell Physiol. 34): C571-C576, 1993.
17. Klagsburn, M., and A. Baird. A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229-231, 1991.
18. Ko, Y., A. Sachinidis, A. J. Wieczorek, M. Appenheimer, R. Düsing, and H. Vetter. Insulin enhances angiotensin II-induced DNA synthesis in vascular smooth muscle cells of the rat. Clin. Investig. 71: 379-382, 1993.
19. Ko, Y., H. Stiebler, G. Nickenig, A. J. Wieczorek, H. Vetter, and A. Sachinidis. Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-β on platelet-derived growth factor-ββ, basic fibroblast growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am. J. Hypertens. 6: 496-499, 1993.
20. Lindner, V., and M. A. Reidy. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88: 3739-3743, 1991.
21. Mason, I. J. The ins and outs of fibroblast growth factors. Cell 78: 547-552, 1994.
22. Miano, J. M., N. Vlasic, R. R. Tota, and M. B. Stemerman. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth. Arterioscler. Thromb. 13: 211-219, 1992.
23. Olson, N. E., S. Chao, V. Lindner, and M. A. Reidy. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. Am. J. Pathol. 140: 1017-1023.
24. Pang, S. C., and S. L. Venance. Cultured smooth muscle approach in the study of hypertension. Can. J. Physiol. Pharmacol. 70: 573-579, 1992.
25. Partanen, J., T. P. Makela, E. Earola, J. Korhonen, H. Hirvonen, L. Claesson-Welsh, and K. Atlitalo. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. Eur. Mol. Biol. Organ. J. 10: 1347-1354, 1991.
26. Pfeifle, S., H. Boeder, and H. Ditschuneit. Interaction of receptors for insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells. Endocrinology 120: 2251-2258, 1987.
27. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature Lond. 362: 801-809, 1993.
28. Saito, H., S. Kasayama, H. Kouhara, K. Matsumoto, and B. Sato. Up-regulation of fibroblast growth facotor (FGF) receptor mRNA levels by basic FGF or testosterone in androgen-sensitive mouse mammary tumor cells. Biochem. Biophys. Res. Commun. 174: 136-141, 1991.
29. Sambrook, J., E. Fritsch, and T. Maniatis. Molecular Cloning. A Laboratory Manual, edited by C. Nolan. Cold Spring Harbor, NY: Cold Spring Harbor, 1989, p. 7.37-7.52.
30. Schöllmann, C., R. Grugel, D. Tatje, J. Hoppe, J. Folkman, D. Marmé, and H. A. Weich. Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF-α receptor in vascular smooth muscle cells. J. Biol. Chem. 267: 18032-18039, 1992.
31. Stiles, C. D., G. T. Capone, C. D. Scher, H. N. Antoniades, J. J. Van Wyk, and W. J. Pledger. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 76: 1279-1283, 1979.
32. Ververis, J. J., L. Ku, and P. Delafontaine. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ. Res. 72: 1285-1292, 1993.
33. Ververis, J., L. Ku, and P. Delafontaine. Fibroblast growth factor regulates insulin-like growth factor-binding protein production by vascular smooth muscle cells. Am. J. Med. Sci. 307: 77-81, 1994.
34. Wilcox, J. N. Molecular biology: insight into the causes and prevention of restenosis after arterial intervention. Am. J. Cardiol. 72: 88E-95E, 1993.
35. Xing, X., A. D. Johnson, T. Scott-Burden, D. Engler, and W. Casscells. The predominant form of fibroblast growth factor receptor expressed by proliferating human arterial smooth muscle cells in culture is type I. Biochem. Biophys. Res. Commun. 204: 557-564, 1994.
36. Yeoman, L. C. An autocrine model for cell- and matrix-associated fibroblast growth factor. Oncol. Res. 5: 489-499, 1993.